People In Brief
This article was originally published in The Tan Sheet
Executive Summary
Jakobsen next in line as Mead Johnson CEO; Blake takes over Bayer U.S. from Babe; Himmel ends brief tenure as ChromaDex CEO; Capitol Hill veteran O’Donnell joins NACDS; Merz makes Hartman derma VP; USANA strengthens scientist roster; more People In Brief.
You may also be interested in...
ChromaDex Looks To Pharma Model For Commercializing Supplement Research
Nutritional ingredient developer ChromaDex is employing a pharma-style business model to expand its R&D into finished dietary supplements – with a long-term eye on pharmaceutical products. The firm’s recent hire of CEO Jeffrey Himmel was a significant step into the consumer products arena.
In Brief
Canada shifts energy drinks, possibly other NHPs to foods; Consumer Reports takes on fish oil; OTC diabetic products lift Hi-Tech sales; MJN restructures management and LipiGesic M sold at CVS, Walgreens
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.